<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Quinolones; Nalidixic acid; Norfloxacin; Ciprofloxacin; Chlamydia: quinolones, in; Ofloxacin; Levofloxacin; Moxifloxacin; Anthrax: antibacterial treatment" /><meta name="IX" content="Quinolones; Nalidixic acid; Norfloxacin; Ciprofloxacin; Chlamydia: quinolones, in; Ofloxacin; Levofloxacin; Moxifloxacin; Anthrax: antibacterial treatment" /><title>5.1.12 Quinolones: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3658-quinolones.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3658-quinolones.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3658-quinolones.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP3253-infections.htm">5 Infections</a> &gt; <a href="PHP3256-antibacterial-drugs.htm">5.1 Antibacterial drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3655-tinidazole.htm" title="Previous: TINIDAZOLE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3665-ciprofloxacin.htm" title="Next: CIPROFLOXACIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1><span>5.1.12 </span>Quinolones</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int193-quinolones.htm">Quinolones</a>).</p></div></div><p><strong>Nalidixic acid</strong> and <strong>norfloxacin</strong> are effective in uncomplicated urinary-tract infections.</p> <p><strong>Ciprofloxacin</strong> is active against both Gram-positive and Gram-negative bacteria. It is particularly active against Gram-negative bacteria, including salmonella, shigella, campylobacter, neisseria, and pseudomonas. Ciprofloxacin has only moderate activity against Gram-positive bacteria such as <em>Streptococcus pneumoniae</em> and <em>Enterococcus faecalis</em>; it should not be used for pneumococcal pneumonia. It is active against chlamydia and some mycobacteria. Most anaerobic organisms are not susceptible. Ciprofloxacin can be used for respiratory tract infections (but not for pneumococcal pneumonia), urinary-tract infections, infections of the gastro-intestinal system (including typhoid fever), bone and joint infections, gonorrhoea and septicaemia caused by sensitive organisms.</p> <p><strong>Ofloxacin</strong> is used for urinary-tract infections, lower respiratory-tract infections, gonorrhoea, and non-gonococcal urethritis and cervicitis.</p> <p><strong>Levofloxacin</strong> is active against Gram-positive and Gram-negative organisms. It has greater activity against pneumococci than ciprofloxacin. Levofloxacin is licensed for community-acquired pneumonia but it is considered to be <strong>second-line treatment</strong> for this indication.</p> <p>Although ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin are licensed for skin and soft-tissue infections, many staphylococci are resistant to the quinolones and their use should be avoided in MRSA infections.</p> <p><strong>Moxifloxacin</strong> should be reserved for the treatment of sinusitis, community-acquired pneumonia, exacerbations of chronic bronchitis, mild to moderate pelvic inflammatory disease, or complicated skin and soft-tissue infections which have failed to respond to other antibacterials or for patients who cannot be treated with other antibacterials. It has been associated with QT interval prolongation and life-threatening hepatotoxicity. Moxifloxacin is active against Gram-positive and Gram-negative organisms. It has greater activity against Gram-positive organisms, including pneumococci, than ciprofloxacin. Moxifloxacin is not active against <em>Pseudomonas aeruginosa</em> or meticillin-resistant <em>Staphylococcus aureus</em> (MRSA).</p> <div id="PHP3659"><h2>Anthrax</h2><p><em>Inhalation</em> or <em>gastro-intestinal anthrax</em> should be treated initially with either <strong>ciprofloxacin</strong> [not licensed for gastro-intestinal anthrax] or <strong>doxycycline</strong> [unlicensed indication] (<a title="Tetracyclines" href="PHP3425-tetracyclines.htm">section 5.1.3</a>) combined with one or two other antibacterials (such as amoxicillin, benzylpenicillin, chloramphenicol, clarithromycin, clindamycin, imipenem with cilastatin, rifampicin [unlicensed indication], and vancomycin). When the condition improves and the sensitivity of the <em>Bacillus anthracis</em> strain is known, treatment may be switched to a single antibacterial. Treatment should continue for 60 days because germination may be delayed.</p><p><em>Cutaneous anthrax</em> should be treated with either ciprofloxacin [unlicensed indication] or doxycycline [unlicensed indication] (<a title="Tetracyclines" href="PHP3425-tetracyclines.htm">section 5.1.3</a>) for 7 days. Treatment may be switched to amoxicillin (<a title="monograph: AMOXICILLIN" href="PHP3327-amoxicillin.htm">section 5.1.1.3</a>) if the infecting strain is susceptible. Treatment may need to be extended to 60 days if exposure is due to aerosol. A combination of antibacterials for 14 days is recommended for cutaneous anthrax with systemic features, extensive oedema, or lesions of the head or neck.</p><p>Ciprofloxacin or doxycycline may be given for <em>post-exposure prophylaxis</em>. If exposure is confirmed, antibacterial prophylaxis should continue for 60 days. Antibacterial prophylaxis may be switched to amoxicillin after 10–14 days if the strain of <em>B. anthracis</em> is susceptible. Vaccination against anthrax (<a title="Anthrax vaccine" href="PHP8244-anthrax-vaccine.htm">section 14.4</a>) may allow the duration of antibacterial prophylaxis to be shortened.</p></div> <div id="PHP3660"><h2>Cautions</h2><p>Quinolones should be used with caution in patients with a history of epilepsy or conditions that predispose to seizures, in G6PD deficiency (<a title=" G6PD deficiency" href="PHP5935-g6pd-deficiency.htm">section 9.1.5</a>), myasthenia gravis (risk of exacerbation), and in children or adolescents (arthropathy has developed in weight-bearing joints in young <em>animals</em>—see below). Exposure to excessive sunlight should be avoided (discontinue if photosensitivity occurs). Quinolones can prolong the QT interval. Moxifloxacin is contra-indicated in patients with risk factors for QT interval prolongation (e.g. electrolyte disturbances, acute myocardial infarction, heart failure with reduced left ventricular ejection fraction, bradycardia, congenital long QT syndrome, concomitant use with other drugs known to prolong the QT interval, history of symptomatic arrhythmias) and the other quinolones should be used with caution in these patients. The CSM has warned that quinolones may induce <strong>convulsions</strong> in patients with or without a history of convulsions; taking NSAIDs at the same time may also induce them. Other <strong>interactions:</strong> Appendix 1 (quinolones).</p><div class="cF"><div class="cE"><h3 class="cT">Use in children</h3> <p class="cT">Quinolones cause arthropathy in the weight-bearing joints of immature <em>animals</em> and are therefore generally not recommended in children and growing adolescents. However, the significance of this effect in humans is uncertain and in some specific circumstances short-term use of either ciprofloxacin or nalidixic acid may be justified in children. For further details see <a title="BNFC:sub-section: Quinolones" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP12885.htm"><em>BNF for Children</em></a>.</p></div></div></div> <div class="cI"><h3 class="cT">Tendon damage</h3><p>Tendon damage (including rupture) has been reported rarely in patients receiving quinolones. Tendon rupture may occur within 48 hours of starting treatment; cases have also been reported several months after stopping a quinolone. Healthcare professionals are reminded that:</p><ul><li><p>quinolones are contra-indicated in patients with a history of tendon disorders related to quinolone use;</p> </li><li><p>patients over 60 years of age are more prone to tendon damage;</p> </li><li><p>the risk of tendon damage is increased by the concomitant use of corticosteroids;</p> </li><li><p>if tendinitis is suspected, the quinolone should be discontinued immediately.</p> </li></ul></div> <div><h2>Contra-indications</h2><p>quinolone hypersensitivity. See also <a title="BNF:target-block: Quinolone cautions" href="PHP3658-quinolones.htm#PHP3660">Cautions above</a>.</p></div> <div id="PHP3663"><h2>Pregnancy</h2><p>Quinolones should be avoided in pregnancy because they have been shown to cause arthropathy in <em>animal</em> studies; safer alternatives are available; however, a single dose of ciprofloxacin may be used for the prevention of a secondary case of meningococcal meningitis</p></div> <div id="PHP3664"><h2>Side-effects</h2><p>Side-effects of the quinolones include nausea, vomiting, dyspepsia, abdominal pain, diarrhoea (rarely antibiotic-associated colitis), headache, dizziness, rash (very rarely Stevens-Johnson syndrome and toxic epidermal necrolysis). Less frequent side-effects include anorexia, sleep disturbances, asthenia, confusion, anxiety, depression, hallucinations, tremor, blood disorders (including eosinophilia, leucopenia, thrombocytopenia), arthralgia, myalgia, disturbances in vision and taste. Other side-effects reported rarely or very rarely include hepatic dysfunction (including jaundice and hepatitis), hypotension, vasculitis, dyspnoea (more frequent with moxifloxacin), convulsions, psychoses, paraesthesia, renal failure, interstitial nephritis, tendon inflammation and damage (see also Tendon Damage above), photosensitivity, disturbances in hearing and smell. The drug should be <strong>discontinued</strong> if psychiatric, neurological or hypersensitivity reactions (including severe rash) occur.</p></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP3665-ciprofloxacin"><a href="PHP3665-ciprofloxacin.htm" title="CIPROFLOXACIN">CIPROFLOXACIN</a></li><li id="_PHP3668-levofloxacin"><a href="PHP3668-levofloxacin.htm" title="LEVOFLOXACIN">LEVOFLOXACIN</a></li><li id="_PHP3671-moxifloxacin"><a href="PHP3671-moxifloxacin.htm" title="MOXIFLOXACIN">MOXIFLOXACIN</a></li><li id="_PHP3673-nalidixic-acid"><a href="PHP3673-nalidixic-acid.htm" title="NALIDIXIC ACID">NALIDIXIC ACID</a></li><li id="_PHP3675-norfloxacin"><a href="PHP3675-norfloxacin.htm" title="NORFLOXACIN">NORFLOXACIN</a></li><li id="_PHP3678-ofloxacin"><a href="PHP3678-ofloxacin.htm" title="OFLOXACIN">OFLOXACIN</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3655-tinidazole.htm">Previous: TINIDAZOLE</a> | <a class="top" href="PHP3658-quinolones.htm#">Top</a> | <a accesskey="]" href="PHP3665-ciprofloxacin.htm">Next: CIPROFLOXACIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>